Plain-English translation of NCT05384756 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Read our Sickle Cell Disease research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
United States
Phase
Safety & dosing
Sponsor
City of Hope Medical Center
Collaborators
National Cancer Institute (NCI)
Enrollment target
~20 participants
Started
July 2022
Primary completion
December 2026
Age range
12 Years – 40 Years
Last updated on clinicaltrials.gov in July 2026.